Vera Therapeutics, Inc. (VERA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.25B |
| Enterprise Value | 2.98B |
| P/E Ratio | -6.33 |
| PEG Ratio | 0.13 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 5.02 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -6.95 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.59 |
| Return On Equity | -0.75 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -291.62M |
| Net Income | -299.62M |
| Diluted EPS | -4.66 |
| Total Cash | 596.76M |
| Total Cash/Share | 8.35 |
| Total Debt | 75.03M |
| Total Debt/Equity | 0.15 |
| Current Ratio | 13.64 |
| Book Value Per Share | 6.99 |
| 52-Week Change | 62.08 |
| 52-Week High | 56.05 |
| 52-Week Low | 19.07 |
| Moving Average 50 Days | 36.46 |
| Moving Average 200 Days | 37.17 |
| Average Volume | 1.13M |
| Shares Outstanding | 71.78M |
| % Held by Institutions | 112.46 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |